|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Cedars-Sinai Medical Center, Pulmonary Division, Department of Medicine, Los Angeles
2 From the Department of Cardiothoracic Surgery, UCLA School of Medicine, Los Angeles
The presentation and clinical course of bronchiolitis obliterans (BO) in single-lung transplant (SLT) recipients has thus far not been well described. We retrospectively analyzed the serial spirometry of 15 SLT patients with BO. All the patients fulfilled the criteria for BO syndrome, and 11 of the 15 had histologically documented BO. Based on serial FEV1 analysis, we identified three patterns of presentation and progression of BO. The first pattern (n=6) was characterized by a rapid onset and a relentless progressive course; the second pattern (n=5) was characterized by a similar rapid onset and initial rapid decline, but was followed by stabilization in lung function; the third pattern (n=4) was characterized by an insidious onset and course. In all patients, a permanent reduction in the mean forced expiratory flow during the middle half of the forced vital capacity appeared to be an early sensitive index for the development of BO. An appreciation of these different modes of presentation and progression of BO is potentially important in the assessment of prognosis and management of the SLT recipient.
Key Words: bronchiolitis obliterans chronic rejection lung transplantation spirometry
Submitted on April 4, 1994
Accepted on August 17, 2007
This article has been cited by other articles:
![]() |
O. Brugiere, G. Thabut, H. Mal, A. Marceau, G. Dauriat, R. Marrash-Chahla, Y. Castier, G. Leseche, M. Colombat, and M. Fournier Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome Eur. Respir. J., May 1, 2005; 25(5): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, T. De Giacomo, E. A. Rendina, S. Quattrucci, E. Mercadante, G. Cimino, M. Ibrahim, D. Diso, A. Bachetoni, and G. F. Coloni Recovery of Chronic Renal Impairment With Sirolimus After Lung Transplantation Ann. Thorac. Surg., December 1, 2004; 78(6): 1940 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boehler and M. Estenne Post-transplant bronchiolitis obliterans Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Griffith and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426. [Full Text] |
||||
![]() |
R. M. Aris, S. Walsh, W. Chalermskulrat, V. Hathwar, and I. P. Neuringer Growth Factor Upregulation during Obliterative Bronchiolitis in the Mouse Model Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Brugiere, F. Pessione, G. Thabut, H. Mal, G. Jebrak, G. Leseche, and M. Fournier Bronchiolitis Obliterans Syndrome After Single-Lung Transplantation* : Impact of Time to Onset on Functional Pattern and Survival Chest, June 1, 2002; 121(6): 1883 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-S. Lee, M. B. Gotway, G. P. Reddy, J. A. Golden, F. M. Keith, and W. R. Webb Early Bronchiolitis Obliterans Following Lung Transplantation: Accuracy of Expiratory Thin-Section CT for Diagnosis Radiology, August 1, 2000; 216(2): 472 - 477. [Abstract] [Full Text] |
||||
![]() |
S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF] |
||||
![]() |
R. I. Whyte, S. J. Rossi, M. S. Mulligan, R. Florn, L. Baker, S. Gupta, F. J. Martinez, and J. P. Lynch III Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation Ann. Thorac. Surg., October 1, 1997; 64(4): 945 - 948. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |